Emerging Agents for Progressive Multiple Sclerosis

Released On
June 14, 2018

Expires On
June 14, 2019

Media Type

Completion Time
60 minutes


Multiple Sclerosis

Scroll to the Bottom of this Information to Begin this Course

Jointly provided by Consortium of Multiple Sclerosis Centers and PlatformQ Health Education, LLC.


Supported by an educational grant from Genentech, Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

General CME/CNE/CE Information

In order to successfully complete this continuing education activity, the participant must register for the activity, attend the activity, and complete the online Evaluation and Claim for Credit form.

Target Audience

Neurologists, primary care physicians, physician assistants (PAs), nursing professionals, and other members of the care team who manage patients with MS.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate new knowledge on challenges and barriers in the management of progressive MS into clinical decision-making
  • Compare and contrast the safety and efficacy of disease-modifying therapies used in relapsing-remitting MS to current and emerging treatment options for progressive MS
  • Establish a treatment monitoring plan for progressive MS
  • Summarize the mechanisms of action and potential therapeutic benefit of emerging agents in appropriate patients with progressive MS


Jerry S. Wolinsky, MD

Emeritus Professor in Neurology
McGovern Medical School, UTHealth Houston

Edward J. Fox, MD, PhD

Director, MS Clinic of Central Texas
Central Texas Neurology Consultants, PA
Clinical Associate Professor of Neurology
University of Texas Dell Medical School

Lori Mayer, DNP, MSCN

Director, Medical Research
Central Texas Neurology Consultants, PA

Accreditation and Credit Information

In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC), and PlatformQ Health Education. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The CMSC designates this enduring material for a maximum of 1.0 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Certificate of Completion

A Certificate of Completion may be given upon completion of course requirements enabling you to register your credit with the appropriate licensing boards or associations. You may apply for other accreditations using the procedure established by the specific organization.

Disclosure of Unlabeled Use

CMSC and PlatformQ Health Education require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions for Participation and Credit

There are no fees to participate in this activity. To participate in the activity, go to http://www.cmscscholar.com" or www.NeuroSeriesLive.com. To receive credit, participants must (1) read the activity front matter, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

Disclosure of Financial Relationships

It is the policy of CMSC, NPA, and PlatformQ Health Education to ensure balance, independence, objectivity, and scientific rigor in all educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed any relevant financial relationships they or their spouse/life partner have within the previous 12 months with manufacturers of any commercial products/devices and/or providers of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. All presentations were reviewed by an independent clinician with no relevant financial relationships for the purpose of resolution of any identified conflict of interest and a determination of evidence-base and fair balance.

Faculty Disclosures

The faculty reported the following financial relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Edward J. Fox, MD served as faculty for this activity. He has received consulting fees from Acorda, Bayer, Biogen, EMD Serono, Genentech, Novartis, Sanofi Genzyme, and Teva. He has served on the speaker’s bureau for Acorda, Biogen, EMD Serono, Genentech, Novartis, Sanofi Genzyme, and Teva. He has received funding for research from AbbVie, Biogen, Celgene, Chugai, EMD Serono, Genentech, Mallinckrodt, MedDay, Novartis, Roche, Sanofi Genzyme, Teva, and TG Therapeutics.

Lori Mayer, DNP, MSCN served as faculty for this activity. She has received consulting fees from EMD Serono, Genentech, and Genzyme. She has also served on the speakers’ bureau for EMD Serono, Genentech, and Genzyme.

Jerry S. Wolinsky, MD served as faculty for this activity. He has received royalties from Millipore (Chemicon International) Corporation, and compensation for consulting, serving on a scientific advisory board, speaking, or other activities with AbbVie, Actelion, Alkermes, Biogen, and Bionest. He has served on the speakers’ bureau for Celgene, Clene Nanomedicine, EMD Serono, Forward Pharma A/S, GeNeuro, MedDay Pharmaceuticals, Novartis, Otsuka, PTC Therapeutics, Roche/Genentech, and Sanofi-Genzyme.

All other CMSC and PlatformQ Health Education staff who are in a position to influence content have disclosed no relevant financial relationships.

Hardware and Software Requirements

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

Contact Information

If you have questions about this CME/CNE activity, please contact the CMSC at education@mscare.org or 201-487-1050.

For technical problems with the site or issues with your certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.

PlatformQ Health Privacy Policy:

By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here describes (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.

Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.

In plain English, here is what we affirm:

  • You can change your registration profile at any time from our “Profile” page
  • To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
  • You can end your association with PlatformQ Health at any time
  • PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
  • EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting support@platformq.com with the subject line “Data Request”

You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/